F344.ZUC-Leprfa/Tj |
epididymal fat pad weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
epididymal fat pad mass |
male |
168 days-175 days |
5 |
14.16 |
g |
0.42 |
0.94 |
post excision weight measurement |
0.0 |
0 |
|
97732 |
1918 |
F344/NSlc |
retroperitoneal fat pad weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
retroperitoneal fat pad mass |
male |
168 days-175 days |
5 |
9.35 |
g |
0.77 |
1.72 |
post excision weight measurement |
0.0 |
0 |
|
97722 |
1918 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
retroperitoneal fat pad weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
retroperitoneal fat pad mass |
male |
168 days-175 days |
12 |
7.81 |
g |
0.41 |
1.42 |
post excision weight measurement |
0.0 |
0 |
|
97723 |
1918 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum total cholesterol level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood cholesterol amount |
male |
168 days-175 days |
7 |
42.69 |
mg/dl |
5.25 |
13.89 |
serum total cholesterol measurement test |
0.0 |
0 |
T-CHO-E test kits, Wako Chem. Ltd. Osaka, Japan |
97747 |
1918 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
mesenteric fat pad weight to body weight ratio |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
mesenteric fat pad mass |
male |
168 days-175 days |
5 |
1.7 |
% |
0.13 |
0.29 |
post excision weight measurement |
0.0 |
0 |
|
97739 |
1918 |
F344.ZUC-Leprfa/Tj |
retroperitoneal fat pad weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
retroperitoneal fat pad mass |
male |
168 days-175 days |
5 |
33.57 |
g |
0.83 |
1.86 |
post excision weight measurement |
0.0 |
0 |
|
97724 |
1918 |
F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj |
epididymal fat pad weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
epididymal fat pad mass |
male |
168 days-175 days |
9 |
10.06 |
g |
0.45 |
1.35 |
post excision weight measurement |
0.0 |
0 |
|
97733 |
1918 |
F344/NSlc |
epididymal fat pad weight to body weight ratio |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
epididymal fat pad mass |
male |
168 days-175 days |
5 |
2.7 |
% |
0.22 |
0.49 |
post excision weight measurement |
0.0 |
0 |
|
97742 |
1918 |
F344/NSlc |
serum triglyceride level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood triglyceride amount |
male |
168 days-175 days |
7 |
130.17 |
mg/dl |
15.88 |
42.01 |
serum triglyceride analysis |
0.0 |
0 |
TG-E test kits, Wako Chem. Ltd. Osaka, Japan |
97750 |
1918 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
body weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
body mass |
male |
168 days-175 days |
22 |
301.64 |
g |
7.17 |
33.63 |
body weighing method |
0.0 |
0 |
|
97719 |
1918 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
epididymal fat pad weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
epididymal fat pad mass |
male |
168 days-175 days |
12 |
6.45 |
g |
0.27 |
0.94 |
post excision weight measurement |
0.0 |
0 |
|
97731 |
1918 |
F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj |
retroperitoneal fat pad weight to body weight ratio |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
retroperitoneal fat pad mass |
male |
168 days-175 days |
9 |
4.9 |
% |
0.06 |
0.18 |
post excision weight measurement |
0.0 |
0 |
|
97737 |
1918 |
F344/NSlc |
serum total cholesterol level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood cholesterol amount |
male |
168 days-175 days |
7 |
45.77 |
mg/dl |
4.03 |
10.66 |
serum total cholesterol measurement test |
0.0 |
0 |
T-CHO-E test kits, Wako Chem. Ltd. Osaka, Japan |
97746 |
1918 |
F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj |
mesenteric fat pad weight to body weight ratio |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
mesenteric fat pad mass |
male |
168 days-175 days |
7 |
2.0 |
% |
0.08 |
0.21 |
post excision weight measurement |
0.0 |
0 |
|
97741 |
1918 |
F344.ZUC-Leprfa/Tj |
body weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
body mass |
male |
168 days-175 days |
16 |
590.04 |
g |
7.75 |
31.0 |
body weighing method |
0.0 |
0 |
|
97720 |
1918 |
F344/NSlc |
body weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
body mass |
male |
168 days-175 days |
20 |
380.2 |
g |
12.73 |
56.93 |
body weighing method |
0.0 |
0 |
|
97718 |
1918 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
mesenteric fat pad weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
mesenteric fat pad mass |
male |
168 days-175 days |
5 |
5.23 |
g |
0.57 |
1.27 |
post excision weight measurement |
0.0 |
0 |
|
97727 |
1918 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
epididymal fat pad weight to body weight ratio |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
epididymal fat pad mass |
male |
168 days-175 days |
12 |
2.1 |
% |
0.1 |
0.35 |
post excision weight measurement |
0.0 |
0 |
|
97743 |
1918 |
F344.ZUC-Leprfa/Tj |
epididymal fat pad weight to body weight ratio |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
epididymal fat pad mass |
male |
168 days-175 days |
5 |
2.5 |
% |
0.05 |
0.11 |
post excision weight measurement |
0.0 |
0 |
|
97744 |
1918 |
F344.ZUC-Leprfa/Tj |
mesenteric fat pad weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
mesenteric fat pad mass |
male |
168 days-175 days |
10 |
13.89 |
g |
0.44 |
1.39 |
post excision weight measurement |
0.0 |
0 |
|
97728 |
1918 |
F344.ZUC-Leprfa/Tj |
mesenteric fat pad weight to body weight ratio |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
mesenteric fat pad mass |
male |
168 days-175 days |
10 |
2.4 |
% |
0.09 |
0.28 |
post excision weight measurement |
0.0 |
0 |
|
97740 |
1918 |
F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj |
adipocyte basal free fatty acid secretion |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
adipocyte free fatty acid secretion trait |
male |
168 days-175 days |
10 |
1.23 |
mEq/l |
0.24 |
0.76 |
lipolysis assay measuring free fatty acid release |
0.0 |
0 |
NEFA-C test kits, Wako Chem. Ltd. Osaka, Japan |
97757 |
1918 |
F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj |
body weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
body mass |
male |
168 days-175 days |
5 |
461.5 |
g |
13.65 |
30.52 |
body weighing method |
0.0 |
0 |
|
97721 |
1918 |
F344/NSlc |
mesenteric fat pad weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
mesenteric fat pad mass |
male |
168 days-175 days |
10 |
7.67 |
g |
0.3 |
0.95 |
post excision weight measurement |
0.0 |
0 |
|
97726 |
1918 |
F344/NSlc |
retroperitoneal fat pad weight to body weight ratio |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
retroperitoneal fat pad mass |
male |
168 days-175 days |
5 |
2.4 |
% |
0.18 |
0.4 |
post excision weight measurement |
0.0 |
0 |
|
97734 |
1918 |
F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj |
serum triglyceride level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood triglyceride amount |
male |
168 days-175 days |
10 |
1240.6 |
mg/dl |
209.56 |
662.69 |
serum triglyceride analysis |
0.0 |
0 |
TG-E test kits, Wako Chem. Ltd. Osaka, Japan |
97753 |
1918 |
F344/NSlc |
adipocyte basal free fatty acid secretion |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
adipocyte free fatty acid secretion trait |
male |
168 days-175 days |
7 |
0.44 |
mEq/l |
0.03 |
0.08 |
lipolysis assay measuring free fatty acid release |
0.0 |
0 |
NEFA-C test kits, Wako Chem. Ltd. Osaka, Japan |
97754 |
1918 |
F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj |
mesenteric fat pad weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
mesenteric fat pad mass |
male |
168 days-175 days |
7 |
11.45 |
g |
0.64 |
1.69 |
post excision weight measurement |
0.0 |
0 |
|
97729 |
1918 |
F344/NSlc |
epididymal fat pad weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
epididymal fat pad mass |
male |
168 days-175 days |
5 |
9.79 |
g |
1.12 |
2.5 |
post excision weight measurement |
0.0 |
0 |
|
97730 |
1918 |
F344.ZUC-Leprfa/Tj |
retroperitoneal fat pad weight to body weight ratio |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
retroperitoneal fat pad mass |
male |
168 days-175 days |
5 |
5.8 |
% |
0.2 |
0.45 |
post excision weight measurement |
0.0 |
0 |
|
97736 |
1918 |
F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj |
epididymal fat pad weight to body weight ratio |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
epididymal fat pad mass |
male |
168 days-175 days |
9 |
2.3 |
% |
0.8 |
2.4 |
post excision weight measurement |
0.0 |
0 |
|
97745 |
1918 |
F344.ZUC-Leprfa/Tj |
serum total cholesterol level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood cholesterol amount |
male |
168 days-175 days |
10 |
426.24 |
mg/dl |
30.04 |
94.99 |
serum total cholesterol measurement test |
0.0 |
0 |
T-CHO-E test kits, Wako Chem. Ltd. Osaka, Japan |
97748 |
1918 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
adipocyte basal free fatty acid secretion |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
adipocyte free fatty acid secretion trait |
male |
168 days-175 days |
7 |
0.39 |
mEq/l |
0.03 |
0.08 |
lipolysis assay measuring free fatty acid release |
0.0 |
0 |
NEFA-C test kits, Wako Chem. Ltd. Osaka, Japan |
97755 |
1918 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
retroperitoneal fat pad weight to body weight ratio |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
retroperitoneal fat pad mass |
male |
168 days-175 days |
12 |
2.5 |
% |
0.18 |
0.62 |
post excision weight measurement |
0.0 |
0 |
|
97735 |
1918 |
F344/NSlc |
mesenteric fat pad weight to body weight ratio |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
mesenteric fat pad mass |
male |
168 days-175 days |
10 |
1.9 |
% |
0.08 |
0.25 |
post excision weight measurement |
0.0 |
0 |
|
97738 |
1918 |
F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj |
serum total cholesterol level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood cholesterol amount |
male |
168 days-175 days |
10 |
277.94 |
mg/dl |
40.79 |
128.99 |
serum total cholesterol measurement test |
0.0 |
0 |
T-CHO-E test kits, Wako Chem. Ltd. Osaka, Japan |
97749 |
1918 |
F344.ZUC-Leprfa/Tj |
serum triglyceride level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood triglyceride amount |
male |
168 days-175 days |
10 |
2342.86 |
mg/dl |
269.19 |
851.25 |
serum triglyceride analysis |
0.0 |
0 |
TG-E test kits, Wako Chem. Ltd. Osaka, Japan |
97752 |
1918 |
F344.ZUC-Leprfa/Tj |
adipocyte basal free fatty acid secretion |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
adipocyte free fatty acid secretion trait |
male |
168 days-175 days |
10 |
1.62 |
mEq/l |
0.24 |
0.76 |
lipolysis assay measuring free fatty acid release |
0.0 |
0 |
NEFA-C test kits, Wako Chem. Ltd. Osaka, Japan |
97756 |
1918 |
F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj |
retroperitoneal fat pad weight |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
retroperitoneal fat pad mass |
male |
168 days-175 days |
9 |
22.6 |
g |
0.62 |
1.86 |
post excision weight measurement |
0.0 |
0 |
|
97725 |
1918 |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
serum triglyceride level |
control condition |
Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22. |
blood triglyceride amount |
male |
168 days-175 days |
7 |
80.54 |
mg/dl |
8.04 |
21.27 |
serum triglyceride analysis |
0.0 |
0 |
TG-E test kits, Wako Chem. Ltd. Osaka, Japan |
97751 |
1918 |